Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
181.50 GBX | 0.00% | -2.42% | -3.97% |
Jan. 15 | BofA cuts Unite Group but Goldman says 'buy' | AN |
Jan. 14 | GlobalData Expects Rise in FY24 Revenue | MT |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 3.12 | 5.7 | 5.85 | 7.21 | 9.18 | |||||
Return on Total Capital | 4.47 | 7.99 | 8.05 | 9.97 | 12.99 | |||||
Return On Equity % | 4.63 | 15.62 | 20.41 | 39.46 | 58.06 | |||||
Return on Common Equity | 4.63 | 15.62 | 20.41 | 39.46 | 58.06 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 40.09 | 18.89 | 20.34 | 23.27 | 27.61 | |||||
SG&A Margin | 14.74 | 0.39 | - | - | - | |||||
EBITDA Margin % | 19.32 | 25.28 | 24.09 | 27.43 | 30.68 | |||||
EBITA Margin % | 18.87 | 24.5 | 23.14 | 26.73 | 30.28 | |||||
EBIT Margin % | 9.71 | 18.5 | 20.18 | 23.03 | 26.99 | |||||
Income From Continuing Operations Margin % | 3.92 | 12.67 | 13.15 | 12.54 | 11.28 | |||||
Net Income Margin % | 3.92 | 12.67 | 13.15 | 12.54 | 11.28 | |||||
Net Avail. For Common Margin % | 3.92 | 12.67 | 13.15 | 12.54 | 11.28 | |||||
Normalized Net Income Margin | 4.38 | 10.02 | 10.76 | 9.87 | 9.5 | |||||
Levered Free Cash Flow Margin | 23.52 | 21.81 | 28.67 | 20.92 | 19.04 | |||||
Unlevered Free Cash Flow Margin | 25.17 | 23.39 | 30.52 | 25.49 | 26.5 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.51 | 0.49 | 0.46 | 0.5 | 0.54 | |||||
Fixed Assets Turnover | 7.32 | 3.93 | 4.8 | 7.34 | 9.48 | |||||
Receivables Turnover (Average Receivables) | 4.4 | 4.85 | 4.82 | 5.03 | 5 | |||||
Inventory Turnover (Average Inventory) | - | - | - | - | - | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.54 | 0.59 | 0.58 | 0.67 | 0.62 | |||||
Quick Ratio | 0.49 | 0.53 | 0.54 | 0.63 | 0.54 | |||||
Operating Cash Flow to Current Liabilities | 0.38 | 0.46 | 0.41 | 0.42 | 0.46 | |||||
Days Sales Outstanding (Average Receivables) | 82.96 | 75.5 | 75.68 | 72.56 | 72.97 | |||||
Days Outstanding Inventory (Average Inventory) | - | - | - | - | - | |||||
Average Days Payable Outstanding | 31.41 | 23.02 | 23.84 | 21.81 | 20.31 | |||||
Cash Conversion Cycle (Average Days) | - | - | - | - | - | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 73.41 | 84.02 | 219.76 | 649.28 | 500.69 | |||||
Total Debt / Total Capital | 42.33 | 45.66 | 68.73 | 86.65 | 83.35 | |||||
LT Debt/Equity | 66.87 | 77.41 | 211.19 | 638.1 | 493.25 | |||||
Long-Term Debt / Total Capital | 38.56 | 42.07 | 66.05 | 85.16 | 82.11 | |||||
Total Liabilities / Total Assets | 58.63 | 61.45 | 76.87 | 90.56 | 88.26 | |||||
EBIT / Interest Expense | 3.68 | 7.33 | 6.82 | 3.15 | 2.26 | |||||
EBITDA / Interest Expense | 8.18 | 11.27 | 9.04 | 4.01 | 2.73 | |||||
(EBITDA - Capex) / Interest Expense | 7.85 | 10.49 | 8.89 | 3.96 | 2.7 | |||||
Total Debt / EBITDA | 2.89 | 2.28 | 4.62 | 4.39 | 3.26 | |||||
Net Debt / EBITDA | 2.6 | 1.93 | 4.17 | 3.92 | 3.03 | |||||
Total Debt / (EBITDA - Capex) | 3.01 | 2.45 | 4.69 | 4.45 | 3.29 | |||||
Net Debt / (EBITDA - Capex) | 2.71 | 2.08 | 4.24 | 3.97 | 3.06 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 13.1 | 0.11 | 6.11 | 28.47 | 12.29 | |||||
Gross Profit, 1 Yr. Growth % | 20.28 | 127.7 | 14.24 | 47.01 | 33.22 | |||||
EBITDA, 1 Yr. Growth % | 45.65 | 33.04 | -10.06 | 46.27 | 25.64 | |||||
EBITA, 1 Yr. Growth % | 46.88 | 50.17 | 0.23 | 48.4 | 27.23 | |||||
EBIT, 1 Yr. Growth % | 463.18 | 159.84 | 15.76 | 46.6 | 31.61 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -163.08 | 494.74 | 10.18 | 22.49 | 0.98 | |||||
Net Income, 1 Yr. Growth % | -156.17 | 494.74 | 10.18 | 22.49 | 0.98 | |||||
Normalized Net Income, 1 Yr. Growth % | -1.36K | 257.5 | 13.99 | 17.79 | 8.07 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -154.78 | 502.5 | 11.86 | 29.68 | 2.7 | |||||
Accounts Receivable, 1 Yr. Growth % |